Skip to main content
Clinical Trials/IRCT20170429033680N7
IRCT20170429033680N7
Completed
Phase 3

Comparison and evaluation of cognitive impairment and cognitive function changes in patients undergoing coronary artery bypass graft surgery after premedication with doxedmodyntidine and midazolam

Mashhad University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
coronary arteries.
Sponsor
Mashhad University of Medical Sciences
Enrollment
42
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient satisfaction
  • On\-pump surgery
  • Age 40 to 65 years old

Exclusion Criteria

  • A cardiovascular disease and prolonged CPR
  • DVT history in the last 6 months
  • A history of advanced kidney or lung disease
  • Duration of surgery for more than 5 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials